Science & Enterprise subscription

Follow us on Twitter

  • A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital… https://t.co/Op6EDZgwpS
    about 8 hours ago
  • New post on Science and Enterprise: Depression Therapy Licensed for Online Distribution https://t.co/pKWAsbbhAu #Science #Business
    about 8 hours ago
  • The Federal Reserve, the U.S. central bank, released statistics showing in April 2020, manufacturing output dropped… https://t.co/q390P26pNf
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Largest Ever U.S. Manufacturing Decline https://t.co/WkZSpIfnoj #Science #Business
    about 2 days ago
  • Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a… https://t.co/7K5to9yzvX
    about 3 days ago

Please share Science & Enterprise

Covid-19 Therapies Designed with Virtual Reality, A.I.

SARS-CoV-2 protease

Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed. . . . → Read More: Covid-19 Therapies Designed with Virtual Reality, A.I.

GSK, Biotech Partner on Crispr Covid-19 Test

Crispr genome edits illustration

A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline. . . . → Read More: GSK, Biotech Partner on Crispr Covid-19 Test

Venture Producing Covid-19 Antibody Test Kits

SARS-Cov-2 virus

A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies. . . . → Read More: Venture Producing Covid-19 Antibody Test Kits

FDA Analyzing Real-World Evidence on Covid-19

Network pointer

The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic. . . . → Read More: FDA Analyzing Real-World Evidence on Covid-19

Antibody Neutralizes Covid-19, SARS Viruses

David Veesler

An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections. . . . → Read More: Antibody Neutralizes Covid-19, SARS Viruses

Trial Tests Liquid Biopsy Feasibility in Lung Cancer

Blood sample tubes

Companies that offer biotechnology, diagnostics, and analytics are testing liquid biopsies to make personalized diagnosis and care feasible for lung cancer patients. . . . → Read More: Trial Tests Liquid Biopsy Feasibility in Lung Cancer

Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Heart and major blood vessels

A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic. . . . → Read More: Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Survey Tracking Covid-19 Mental Health Impact

Mental health scrabble

A survey is underway in the U.S. to gauge the mental health impact of the Covid-19 pandemic, with data also collected with personal activity trackers. . . . → Read More: Survey Tracking Covid-19 Mental Health Impact

Microsoft, Biotech Examine Covid-19 Immune Response

T-cells illustration

A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Microsoft, Biotech Examine Covid-19 Immune Response

Oxford, AstraZeneca Partner on Covid-19 Vaccine

Covid-19 vaccine infographic

AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford. . . . → Read More: Oxford, AstraZeneca Partner on Covid-19 Vaccine